Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans‐Pacific Partnership Agreement
Intellectual property (IP) protections proposed by the United States for the Trans‐Pacific
Partnership Agreement (TPPA) have sparked widespread alarm about the potential negative …
Partnership Agreement (TPPA) have sparked widespread alarm about the potential negative …
Exploring evergreening: insights from two medicines
HVJ Moir - Australian Economic Review, 2016 - Wiley Online Library
Litigated pharmaceutical patents are a valuable source of data on how much inventiveness
is required for a patent grant and what are the costs of patents. Although innovation is …
is required for a patent grant and what are the costs of patents. Although innovation is …
Assessing the impact of alternative patent systems on the cost of health care: the TPPA and HIV treatment in Vietnam
Abstract In the Trans Pacific partnership Agreement (TPPA) negotiations, the United States
has proposed expanded patent protections that will likely impact the affordability of …
has proposed expanded patent protections that will likely impact the affordability of …
The trans Pacific partnership agreement and access to HIV treatment in Vietnam
ABSTRACT In the Trans Pacific Partnership (TPP) Agreement negotiations, the USA
successfully pursued intellectual property (IP) provisions that will affect the affordability of …
successfully pursued intellectual property (IP) provisions that will affect the affordability of …
TRIPS+ IP Privileges for Pharmaceuticals and Agricultural Chemicals: EU and US Treaties
HVJ Moir - The European Union and the Evolving Architectures of …, 2023 - Springer
Intellectual property (IP) privileges are one of the most contentious areas of international
economic regulation. This chapter uses the example of pharmaceuticals to consider the …
economic regulation. This chapter uses the example of pharmaceuticals to consider the …
The patent price of market access in the AUSFTA
HVJ Moir - Australian Journal of International Affairs, 2015 - Taylor & Francis
New generation trade agreements reach far behind borders, affecting many areas of
domestic policy not previously associated closely with trade. One of the most uneasy of …
domestic policy not previously associated closely with trade. One of the most uneasy of …
Trade treaties and patent policy: searching for a balanced approach
HVJ Moir - Available at SSRN 2529296, 2014 - papers.ssrn.com
Patents were originally designed to encourage technological innovation, which would not
otherwise occur, and which create spillover benefits. Careful design is needed to ensure …
otherwise occur, and which create spillover benefits. Careful design is needed to ensure …
Exploring Evergreening: Estimating the Cost of Low Patent Standards
HVJ Moir - European Policy for Intellectual Property (epip) …, 2016 - papers.ssrn.com
Litigated pharmaceutical patents are a valuable source of data on how much inventiveness
is required for a patent grant and what are the costs of patents. Although innovation is …
is required for a patent grant and what are the costs of patents. Although innovation is …
Reviewing patent policy: an exercise in futility?
HVJ Moir - Prometheus, 2015 - Taylor & Francis
In 1984, Don Lamberton wrote a two-page disclaimer to a review of the Australian patent
system, pointing out that there was nothing economic about the review and that it simply …
system, pointing out that there was nothing economic about the review and that it simply …
[PDF][PDF] Attachment C: Pharmaceuticals: an insight into patent standards and costs
H Moir - 2016 - pc.gov.au
Litigated pharmaceutical patents are a valuable source of data on both how the patent
system actually operates and where savings might be made in pharmaceutical outlays …
system actually operates and where savings might be made in pharmaceutical outlays …